Skip to main content
Log in

Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Probiotics may reduce risk of urinary tract infection by preventing colonization of uropathogens. We aimed to determine the change in the ratio between uropathogens:Lactobacillus (U/L) within the lower urinary tract in response to oral probiotic.

Methods

This was a double-blinded randomized controlled trial of healthy pre-menopausal female volunteers. Participants provided daily voided urine for 3 months including three phases of the trial: 1—baseline, 2—intervention, 3—wash-out. Participants were randomized to an oral probiotic (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) versus placebo. The primary outcome was the U/L ratio of daily voided urine, as determined by an enhanced urine culture method. Analysis included t test of the ratios and separate generalized linear mixed effects models (GLMM) for microbiota diversity.

Results

481 samples of seven female participants with mean age 29.1 years (± 5.3 years) were included in the analysis (probiotic n = 4; placebo n = 3). No adverse events were reported. The placebo and probiotic groups had similar mean U/L ratios with no difference between placebo and probiotic groups in Phases 1–3 (p = 0.90, p = 0.58 and p = 0.72, respectively). The probiotic species were never identified in the voided urine. There were no changes between groups in terms of microbiota diversity.

Conclusion

For young healthy women, the use of oral probiotic did not affect the U/L ratio.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Wilton L, Kollarova M, Heeley E, Shakir S (2003) Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in england. Drug Saf 26:589–597

    Article  CAS  Google Scholar 

  2. Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM (2015) Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol 213:194.e1–194.e8

    Article  Google Scholar 

  3. Beerepoot M, Geerlings S (2016) Non-antibiotic prophylaxis for urinary tract infections. Pathogens. https://doi.org/10.3390/pathogens5020036

    Article  PubMed  PubMed Central  Google Scholar 

  4. Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Hamidi GA, Salami M (2016) Effect of probiotic supplementation on cognitive function and metabolic status in alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8:256

    Article  Google Scholar 

  5. Heiser CR, Ernst JA, Barrett JT, French N, Schutz M, Dube MP (2004) Probiotics, soluble fiber, and l-glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea. J Int Assoc Physicians AIDS Care (Chic) 3:121–129

    Article  Google Scholar 

  6. Pawlowska J, Klewicka E, Czubkowski P, Motyl I, Jankowska I, Libudzisz Z, Teisseyre M, Gliwicz D, Cukrowska B (2007) Effect of lactobacillus casei DN-114001 application on the activity of fecal enzymes in children after liver transplantation. Transplant Proc 39:3219–3221

    Article  CAS  Google Scholar 

  7. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M (2011) Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 108(Suppl 1):4562–4569

    Article  Google Scholar 

  8. Schwenger EM, Tejani AM, Loewen PS (2015) Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 12:CD008772

    Google Scholar 

  9. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW (2003) Oral use of lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 35:131–134

    Article  CAS  Google Scholar 

  10. Reid G, Bruce AW (2001) Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis 183(Suppl 1):S77–S80

    Article  Google Scholar 

  11. Reid G, Beuerman D, Heinemann C, Bruce AW (2001) Probiotic lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 32:37–41

    Article  CAS  Google Scholar 

  12. Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14:11–16

    CAS  PubMed  Google Scholar 

  13. Bruce AW, Reid G (1988) Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 34:339–343

    Article  CAS  Google Scholar 

  14. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE (2012) Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 172:704–712

    Article  CAS  Google Scholar 

  15. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50:1376–1383

    Article  Google Scholar 

  16. Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schreckenberger PC (2014) Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 52:871–876

    Article  Google Scholar 

  17. Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 10:174

    Article  CAS  Google Scholar 

  18. Price TK, Dune T, Hilt EE, Thomas-White KJ, Kliethermes S, Brincat C, Brubaker L, Wolfe AJ, Mueller ER, Schreckenberger PC (2016) The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol 54:1216–1222

    Article  CAS  Google Scholar 

  19. Perez-Moreno MO, Pico-Plana E, Grande-Armas J, Centelles-Serrano MJ, Arasa-Subero M, Ochoa NC, Led By Mo Perez-Moreno MOTSGG (2017) Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study. J Med Microbiol. 66:454–460

    Article  Google Scholar 

Download references

Funding

NIDDK #RO1 DK104718.

Author information

Authors and Affiliations

Authors

Contributions

BJW: project development, data collection, and manuscript writing. TP: project development, data collection, and manuscript writing. CJJ: statistical analysis and manuscript writing. AJW: project development and manuscript writing. ERM: project development and manuscript writing.

Corresponding author

Correspondence to Birte J. Wolff.

Ethics declarations

Conflict of interest

AJ Wolfe: Investigator Initiated Trials from Astellas Scientific and Medical Affairs and from Kimberly Clark Corporation. ER Mueller: Astellas: Investigator initiated research. Boston Scientific: Advisory Board. UroCure: Safety Monitoring Board. UpToDate: Royalties. Butler Snow/Ethicon: Legal Consultation.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wolff, B.J., Price, T.K., Joyce, C.J. et al. Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial. Int Urol Nephrol 51, 2149–2159 (2019). https://doi.org/10.1007/s11255-019-02282-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-019-02282-3

Keywords